Investing Ideas
/
Taiwanese Pharmaceuticals & Biotech Undervalued Dividend Payers

Taiwanese Pharmaceuticals & Biotech Undervalued Dividend Payers

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies available at a discount paying at least a 2% dividend yield.

1 companies

Lotus Pharmaceutical

Market Cap: NT$74.2b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

1795

NT$282.00

1.3%

6.6%